Prognostic Model Based on NAD+ Metabolism-Related Genes Predicts Breast Cancer Outcomes and Guides Immunotherapy
This study constructed and validated a reliable BCa prognosis model based on NMRGs. The model has a good ability for prognosis stratification, showing great potential to serve as an auxiliary tool for identifying patients who benefit from immunotherapy. These findings provide a new strategy for individualized immunotherapy of BCa.
Authors
- Xuanhui Mao
- Zhongyu Jiang
- Li Wang (ORCID: https://orcid.org/0000-0003-2165-0080)
- Jiaqi Ye (ORCID: https://orcid.org/0000-0002-5824-2518)
Institutions
- Quzhou City People's Hospital (CN)
- Jilin Province Tumor Hospital (CN)
Publication Details
- Journal
- Cancer Investigation
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1080/07357907.2025.2594741
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00